This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Assessment With Xenon 133 Single-Photon Emission Computed Tomography and the Tower of London

Nancy C. Andreasen, MD, PhD; Karim Rezai, MD; Randall Alliger, PhD; Victor W. Swayze II, MD; Michael Flaum, MD; Peter Kirchner, MD; Gregg Cohen, MS; Daniel S. O'Leary, PhD

Arch Gen Psychiatry. 1992;49(12):943-958.

Abstract
• The "hypofrontality hypothesis" has been supported by many neuroimaging studies, but not all, perhaps because of heterogeneity of samples. The present study examined three different samples that permitted assessment of a variety of confounders, such as effects of long-term treatment, chronicity of illness, and presenting phenomenology: (1) 13 neuroleptic-naive schizophrenic patients, (2) 23 nonnaive schizophrenic patients who had been relatively chronically ill but were medication free for at least 3 weeks, and (3) 15 healthy normal volunteers. Regional cerebral blood flow was measured using single-photon emission computed tomography with xenon 133 as the tracer. The control condition consisted of looking at undulating colored shapes on a video monitor, while the experimental task was the Tower of London. We observed the Tower of London to be a relatively specific stimulant of the left mesial frontal cortex (probably including parts of the cingulate gyrus) in healthy normal volunteers. Both the neuroleptic-naive and the nonnaive patients lacked this area of activation, as well as a related one in the right parietal cortex (representing the circuitry specifically activated by the Tower of London). Decreased activation occurred only in the patients with high scores for negative symptoms. These results suggest that hypofrontality is related to negative symptoms and is not a long-term effect of neuroleptic treatment or of chronicity of illness.

Author Affiliations
From the Mental Health Clinical Research Center (Drs Andreasen, Alliger, and O'Leary) and the Departments of Psychiatry (Drs Swayze and Flaum and Mr Cohen) and Radiology (Drs Rezai and Kirchner), The University of Iowa Hospitals and Clinics, Iowa City.

Footnotes
Accepted for publication May 28, 1992

Reprint requests to Mental Health Clinical Research Center, The University of Iowa Hospitals and Clinics, 200 Hawkins Dr, Iowa City, IA 52242 (Dr Andreasen).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Auditory Oddball Deficits in Schizophrenia: An Independent Component Analysis of the fMRI Multisite Function BIRN Study
Kim et al.
Schizophr Bull 2009;35:67-81.
ABSTRACT | FULL TEXT  

Antipsychotic Drugs: Comparison in Animal Models of Efficacy, Neurotransmitter Regulation, and Neuroprotection
Lieberman et al.
Pharmacol. Rev. 2008;60:358-403.
ABSTRACT | FULL TEXT  

Dysfunctional and Compensatory Prefrontal Cortical Systems, Genes and the Pathogenesis of Schizophrenia
Tan et al.
Cereb Cortex 2007;17:i171-i181.
ABSTRACT | FULL TEXT  

Effects of {gamma}-Aminobutyric Acid-Modulating Drugs on Working Memory and Brain Function in Patients With Schizophrenia
Menzies et al.
Arch Gen Psychiatry 2007;64:156-167.
ABSTRACT | FULL TEXT  

Abnormalities of Thalamic Activation and Cognition in Schizophrenia
Andrews et al.
Am. J. Psychiatry 2006;163:463-469.
ABSTRACT | FULL TEXT  

Lateral and Medial Hypofrontality in First-Episode Schizophrenia: Functional Activity in a Medication-Naive State and Effects of Short-Term Atypical Antipsychotic Treatment
Snitz et al.
Am. J. Psychiatry 2005;162:2322-2329.
ABSTRACT | FULL TEXT  

Functional dysconnectivity in schizophrenia associated with attentional modulation of motor function
Honey et al.
Brain 2005;128:2597-2611.
ABSTRACT | FULL TEXT  

Chromatin Alterations Associated With Down-regulated Metabolic Gene Expression in the Prefrontal Cortex of Subjects With Schizophrenia
Akbarian et al.
Arch Gen Psychiatry 2005;62:829-840.
ABSTRACT | FULL TEXT  

Specificity of Prefrontal Dysfunction and Context Processing Deficits to Schizophrenia in Never-Medicated Patients With First-Episode Psychosis
MacDonald et al.
Am. J. Psychiatry 2005;162:475-484.
ABSTRACT | FULL TEXT  

Effects of Psychotic State and Task Demand on Prefrontal Function in Schizophrenia: An fMRI Study of Overt Verbal Fluency
Fu et al.
Am. J. Psychiatry 2005;162:485-494.
ABSTRACT | FULL TEXT  

Partial agonism and schizophrenia
Bolonna and Kerwin
Br. J. Psychiatry 2005;186:7-10.
FULL TEXT  

Rostral anterior cingulate cortex dysfunction during error processing in schizophrenia
Laurens et al.
Brain 2003;126:610-622.
ABSTRACT | FULL TEXT  

Mild Procedural Learning Disturbances in Neuroleptic-Naive Patients With Schizophrenia
Scherer et al.
J. Neuropsychiatry Clin. Neurosi. 2003;15:58-63.
ABSTRACT | FULL TEXT  

Response of Cortical Metabolic Deficits to Serotonergic Challenge in Familial Mood Disorders
Kegeles et al.
Am. J. Psychiatry 2003;160:76-82.
ABSTRACT | FULL TEXT  

Regional Specificity in the Neuropathologic Substrates of Schizophrenia: A Morphometric Analysis of Broca's Area 44 and Area 9
Selemon et al.
Arch Gen Psychiatry 2003;60:69-77.
ABSTRACT | FULL TEXT  

Impaired Visual Object Recognition and Dorsal/Ventral Stream Interaction in Schizophrenia
Doniger et al.
Arch Gen Psychiatry 2002;59:1011-1020.
ABSTRACT | FULL TEXT  

Excessive recruitment of neural systems subserving logical reasoning in schizophrenia
Ramsey et al.
Brain 2002;125:1793-1807.
ABSTRACT | FULL TEXT  

Gene Expression Profiling Reveals Alterations of Specific Metabolic Pathways in Schizophrenia
Middleton et al.
J. Neurosci. 2002;22:2718-2729.
ABSTRACT | FULL TEXT  

Age and Regional Cerebral Blood Flow in Schizophrenia: Age Effects in Anterior Cingulate, Frontal, and Parietal Cortex
Schultz et al.
J. Neuropsychiatry Clin. Neurosi. 2002;14:19-24.
ABSTRACT | FULL TEXT  

Focal Gray Matter Density Changes in Schizophrenia
Hulshoff Pol et al.
Arch Gen Psychiatry 2001;58:1118-1125.
ABSTRACT | FULL TEXT  

Abnormal Patterns of Regional Cerebral Blood Flow in Schizophrenia With Primary Negative Symptoms During an Effortful Auditory Recognition Task
Lahti et al.
Am. J. Psychiatry 2001;158:1797-1808.
ABSTRACT | FULL TEXT  

Anterior Cingulate Cortex Activity and Impaired Self-Monitoring of Performance in Patients With Schizophrenia: An Event-Related fMRI Study
Carter et al.
Am. J. Psychiatry 2001;158:1423-1428.
ABSTRACT | FULL TEXT  

Relation of Prefrontal Cortex Dysfunction to Working Memory and Symptoms in Schizophrenia
Perlstein et al.
Am. J. Psychiatry 2001;158:1105-1113.
ABSTRACT | FULL TEXT  

Effect of Schizophrenia on Frontotemporal Activity During Word Encoding and Recognition: A PET Cerebral Blood Flow Study
Ragland et al.
Am. J. Psychiatry 2001;158:1114-1125.
ABSTRACT | FULL TEXT  

Selective Deficits in Prefrontal Cortex Function in Medication-Naive Patients With Schizophrenia
Barch et al.
Arch Gen Psychiatry 2001;58:280-288.
ABSTRACT | FULL TEXT  

Reduced GAP-43 mRNA in Dorsolateral Prefrontal Cortex of Patients with Schizophrenia
Weickert et al.
Cereb Cortex 2001;11:136-147.
ABSTRACT | FULL TEXT  

Physiological Dysfunction of the Dorsolateral Prefrontal Cortex in Schizophrenia Revisited
Callicott et al.
Cereb Cortex 2000;10:1078-1092.
ABSTRACT | FULL TEXT  

Brain Activation Patterns in Schizophrenic and Comparison Volunteers During a Matched-Performance Auditory Recognition Task
Holcomb et al.
Am. J. Psychiatry 2000;157:1634-1645.
ABSTRACT | FULL TEXT  

Selective Relationship Between Prefrontal N-Acetylaspartate Measures and Negative Symptoms in Schizophrenia
Callicott et al.
Am. J. Psychiatry 2000;157:1646-1651.
ABSTRACT | FULL TEXT  

Repeated Assessment of the Tower of Hanoi Test: Reliability and Age Effects
Ahonniska et al.
Assessment 2000;7:297-310.
ABSTRACT  

Regional Neural Dysfunctions in Chronic Schizophrenia Studied With Positron Emission Tomography
Kim et al.
Am. J. Psychiatry 2000;157:542-548.
ABSTRACT | FULL TEXT  

Cognitive Correlates of the Negative, Disorganized, and Psychotic Symptom Dimensions of Schizophrenia
O'Leary et al.
J. Neuropsychiatry Clin. Neurosi. 2000;12:4-15.
ABSTRACT | FULL TEXT  

Specific Relationship Between Prefrontal NeuronalN-Acetylaspartate and Activation of the Working Memory Cortical Network in Schizophrenia
Bertolino et al.
Am. J. Psychiatry 2000;157:26-33.
ABSTRACT | FULL TEXT  

Functional Imaging of Memory Retrieval in Deficit vs Nondeficit Schizophrenia
Heckers et al.
Arch Gen Psychiatry 1999;56:1117-1123.
ABSTRACT | FULL TEXT  

A Unitary Model of Schizophrenia: Bleuler's "Fragmented Phrene" as Schizencephaly
Andreasen
Arch Gen Psychiatry 1999;56:781-787.
ABSTRACT | FULL TEXT  

Synergistic Interactions between Ampakines and Antipsychotic Drugs
Johnson et al.
J. Pharmacol. Exp. Ther. 1999;289:392-397.
ABSTRACT | FULL TEXT  

Recalling Word Lists Reveals "Cognitive Dysmetria" in Schizophrenia: A Positron Emission Tomography Study
Crespo-Facorro et al.
Am. J. Psychiatry 1999;156:386-392.
ABSTRACT | FULL TEXT  

Development of the Tower of London-Revised
Schnirman et al.
Assessment 1998;5:355-360.
ABSTRACT  

Cortical Dysfunction in Schizophrenia During Auditory Word and Tone Working Memory Demonstrated by Functional Magnetic Resonance Imaging
Stevens et al.
Arch Gen Psychiatry 1998;55:1097-1103.
ABSTRACT | FULL TEXT  

The Construct Validity of The Tower of London DX As a Measure of The Executive Functioning of ADHD Children
Culbertson and Zillmer
Assessment 1998;5:215-226.
ABSTRACT  

Functional Hypofrontality and Working Memory Dysfunction in Schizophrenia
Carter et al.
Am. J. Psychiatry 1998;155:1285-1287.
ABSTRACT | FULL TEXT  

S 16924 ((R)-2-{1-[2-(2,3-Dihydro-Benzo[1,4] Dioxin-5-Yloxy)-Ethyl]-Pyrrolidin-3yl}-1-(4-Fluoro-Phenyl)-Ethanone), a Novel, Potential Antipsychotic with Marked Serotonin (5-HT)1A Agonist Properties: I. Receptorial and Neurochemical Profile in Comparison with Clozapine and Haloperidol
Millan et al.
J. Pharmacol. Exp. Ther. 1998;286:1341-1355.
ABSTRACT | FULL TEXT  

S 16924 ((R)-2-{1-[2-(2,3-Dihydro-Benzo[1,4] Dioxin-5-Yloxy)-Ethyl]-Pyrrolidin-3yl}-1-(4-Fluoro-Phenyl)-Ethanone), a Novel, Potential Antipsychotic with Marked Serotonin (5-HT)1A Agonist Properties: II. Functional Profile in Comparison to Clozapine and Haloperidol
Millan et al.
J. Pharmacol. Exp. Ther. 1998;286:1356-1373.
ABSTRACT | FULL TEXT  

Structural Evaluation of the Prefrontal Cortex in Schizophrenia
Buchanan et al.
Am. J. Psychiatry 1998;155:1049-1055.
ABSTRACT | FULL TEXT  

Cerebral Blood Flow Velocity in Acute Schizophrenic Patients : A Transcranial Doppler Ultrasonography Study
Owega et al.
Stroke 1998;29:1149-1154.
ABSTRACT | FULL TEXT  

Characterization of Psychotic Conditions: Use of the Domains of Psychopathology Model
Ratakonda et al.
Arch Gen Psychiatry 1998;55:75-81.
ABSTRACT | FULL TEXT  

Anterior Cingulate Gyrus Dysfunction and Selective Attention Deficits in Schizophrenia: [15O]H2O PET Study During Single-Trial Stroop Task Performance
Carter et al.
Am. J. Psychiatry 1997;154:1670-1675.
ABSTRACT | FULL TEXT  

Measurement of Glutamate and Glutamine in the Medial Prefrontal Cortex of Never-Treated Schizophrenic Patients and Healthy Controls by Proton Magnetic Resonance Spectroscopy
Bartha et al.
Arch Gen Psychiatry 1997;54:959-965.
ABSTRACT  

Schizophrenic Deficits in the Processing of Context: A Test of a Theoretical Model
Servan-Schreiber et al.
Arch Gen Psychiatry 1996;53:1105-1112.
ABSTRACT  

Enhanced Amphetamine Sensitivity and Increased Expression of Dopamine D2 Receptors in Postpubertal Rats after Neonatal Excitotoxic Lesions of the Medial Prefrontal Cortex
Flores et al.
J. Neurosci. 1996;16:7366-7375.
ABSTRACT | FULL TEXT  

Local and Distributed Effects of Apomorphine on Fronto-Temporal Function in Acute Unmedicated Schizophrenia
Fletcher et al.
J. Neurosci. 1996;16:7055-7062.
ABSTRACT | FULL TEXT  

Auditory Attentional Deficits in Patients With Schizophrenia: A Positron Emission Tomography Study
O'Leary et al.
Arch Gen Psychiatry 1996;53:633-641.
ABSTRACT  

Brain Glucose Metabolism During Non--Rapid Eye Movement Sleep in Major Depression: A Positron Emission Tomography Study
Ho et al.
Arch Gen Psychiatry 1996;53:645-652.
ABSTRACT  

Frontal and Temporal Lobe Brain Volumes in Schizophrenia: Relationship to Symptoms and Clinical Subtype
Turetsky et al.
Arch Gen Psychiatry 1995;52:1061-1070.
ABSTRACT  

Abnormally High Neuronal Density in the Schizophrenic Cortex: A Morphometric Analysis of Prefrontal Area 9 and Occipital Area 17
Selemon et al.
Arch Gen Psychiatry 1995;52:805-818.
ABSTRACT  

Clozapine Treatment of Schizophrenia
Pickar and Hsiao
JAMA 1995;274:981-983.
ABSTRACT  

Resting Cerebral Glucose Metabolism in First-Episode and Previously Treated Patients With Schizophrenia Relates to Clinical Features
Gur et al.
Arch Gen Psychiatry 1995;52:657-667.
ABSTRACT  

A Longitudinal Study of Symptom Dimensions in Schizophrenia: Prediction and Patterns of Change
Arndt et al.
Arch Gen Psychiatry 1995;52:352-360.
ABSTRACT  

An In Vivo Study of the Prefrontal Cortex of Schizophrenic Patients at Different Stages of Illness via Phosphorus Magnetic Resonance Spectroscopy
Stanley et al.
Arch Gen Psychiatry 1995;52:399-406.
ABSTRACT  

Neural Circuitry of the Prefrontal Cortex in Schizophrenia
Lewis
Arch Gen Psychiatry 1995;52:269-273.
ABSTRACT  

Prefrontal Cortex and Schizophrenia: A Quantitative Magnetic Resonance Imaging Study
Wible et al.
Arch Gen Psychiatry 1995;52:279-288.
ABSTRACT  

Regional Brain Abnormalities in Schizophrenia Measured With Magnetic Resonance Imaging
Andreasen et al.
JAMA 1994;272:1763-1769.
ABSTRACT  

Thalamic abnormalities in schizophrenia visualized through magnetic resonance image averaging
Andreasen et al.
Science 1994;266:294-298.
ABSTRACT  

Neuropsychological Impairments in Deficit vs Nondeficit Forms of Schizophrenia
Buchanan et al.
Arch Gen Psychiatry 1994;51:804-811.
ABSTRACT  

Risk Factors for Spontaneous Dyskinesia in Schizophrenia
Fenton et al.
Arch Gen Psychiatry 1994;51:643-650.
ABSTRACT  

Schizophrenia
Carpenter and Buchanan
NEJM 1994;330:681-690.
FULL TEXT  

The Neuropsychology of the Prefrontal Cortex
Rezai et al.
Arch Neurol 1993;50:636-642.
ABSTRACT  

Advancing a Neurodevelopmental Origin for Schizophrenia
Bloom
Arch Gen Psychiatry 1993;50:224-227.
ABSTRACT